Studies have linked hypertension and obesity to various heart issues TAMPA, Fla., April 13, 2022 /PRNewswire/ — Smart Meter, a leader in remote patient monitoring (RPM) solutions, helps RPM providers deliver disease and condition-specific products and services to healthcare providers. Cardiovascular Disease (CVD) was responsible for more than 19 million deaths worldwide in […]
Rhythm
AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System
New clamp is designed to improve efficiency of concomitant ablation procedures MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that it has launched the EnCompass Clamp®, a part of […]
Vivalink Biometrics Data Platform Enables Artificial Intelligence and Machine Learning Applications for Healthcare
Vivalink platform’s ability to deliver uninterrupted streams of real-world physiological data enables faster algorithm development for disease detection and diagnosis CAMPBELL, Calif., April 12, 2022 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, has expanded the use of its Biometrics Data Platform to serve companies developing artificial intelligence (AI) and machine […]
Kardium’s Globe® System Begins Clinical Trial at St. Paul’s Hospital
A revolutionary device that treats Atrial Fibrillation (AF) – the world’s most common heart rhythm disorder – helps support the healthy aging of BC’s population. April 12, 2022, 9:00 AM Pacific Daylight Time | VANCOUVER, British Columbia – Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the Globe® Mapping and Ablation […]
Israeli startup Sanolla receives FDA clearance for the world’s first AI-ready infrasound stethoscope
Sanolla’s pioneering technology draws lifesaving medical insights from listening to bodily sounds that cannot be heard by humans The startup’s AI algorithms provide unmatched disease classification for many cardiopulmonary diseases including COPD, pneumonia, asthma, and cardiac morbidities NESHER, Israel, April 11, 2022 /PRNewswire/ — Israeli startup Sanolla, which provides AI-powered primary care diagnostic solutions, announced […]
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award
ASSURE System Honored as One of the Year’s Best Designed Cardiovascular Devices KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the company’s ASSURE® Wearable Cardioverter Defibrillator (WCD) system was recognized as one of the winners of the(MDEA), garnering honors in the Cardiovascular Devices category. The ASSURE® WCD system represents the next generation of monitoring and […]
Study Demonstrates that Cardiologs’ AI Dramatically Reduces Inconclusive Apple Watch ECGs
Data being presented at the EHRA 2022 shows Cardiologs’ deep neural network model is better than Apple Watch ECG 2.0 algorithm at detecting & classifying irregular heart rhythms Paris and Boston, Mass. –April 5, 2022 – Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the results […]
Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
New clinical research presented at ACC.22 shows that the Zio service is a viable solution for the early detection of silent atrial fibrillation Additional data shows that Zio AT can positively impact hospital resources – saving one healthcare system 136 inpatient hospitalization days SAN FRANCISCO, April 03, 2022 (GLOBE NEWSWIRE) — iRhythm […]
ABBOTT RECEIVES FDA APPROVAL FOR AVEIR™ VR LEADLESS PACEMAKER SYSTEM TO TREAT PATIENTS WITH SLOW HEART RHYTHMS
Abbott’s Aveir single chamber (VR) pacing system is the world’s only leadless pacemaker with a unique mapping capability to assess correct positioning prior to placement Aveir VR has an increased projected battery life that can be up to two times longer than other commercially available leadless pacemakers when using the […]
Aziyo Announces FDA 510(k) Submission for CanGaroo® RM, its Next-Generation Biomaterial Envelope Enhanced with Antibiotics
SILVER SPRING, Md., April 04, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), today announced the Company has filed a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for CanGaroo® RM Antibacterial Envelope, its next-generation biomaterial envelope for use with implantable electronic devices (IED). Aziyo Biologics is […]



